bioRxivBiochemistry
Deep mutational scan of a drug efflux pump reveals its structure-function landscape
G. Meier, S. Thavarasah, K. Ehrenbolger, C. A. J. Hutter, L. M. Hürlimann, J. Barandun, M. A. Seeger
Abstract
Drug efflux is a common resistance mechanism found in bacteria and cancer cells. Although several structures of drug efflux pumps are available, they provide only limited functional information on the phenomenon of drug efflux. Here, we performed deep mutational scanning (DMS) on the bacterial ATP binding cassette (ABC) transporter EfrCD to determine the drug efflux activity profile of more than 1500 single variants. These systematic measurements revealed that the introduction of negative charges at different locations within the large substrate binding pocket results in strongly increased efflux activity towards positively charged ethidium, while additional aromatic residues did not display the same effect. Data analysis in the context of an inward-facing cryo-EM structure of EfrCD uncovered a high affinity binding site, which releases bound drugs through a peristaltic transport mechanism as the transporter transits to its outward-facing conformation. Finally, we identified substitutions resulting in rapid Hoechst influx without affecting the efflux activity for ethidium and daunorubicin. Hence, single mutations can convert the ABC exporter EfrCD into a drug-specific ABC importer.
- organism: bacteria (other)
- assay: ATAC-seq
- assay: structural biology
- research focus: protein folding & dynamics
- research focus: drug response / drug discovery
- approach: experimental assay
- approach: deep learning
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structural basis of drug efflux by the staphylococcal efflux pump QacA
Léni Jodaitis, Patrick Sutton, … Cédric Govaerts·bioRxiv·Apr 14, 2026
- Targeted Molecular Dynamics Simulations Suggest Direct Ligand Competition as a Plausible Efflux Inhibition Mechanism in the Multidrug Resistance Pump AcrB.
Lande Vieira da Silva, Pedro Eduardo Almeida da Silva, … Terry P. Lybrand·bioRxiv·Jun 5, 2018
- Perturbed structural dynamics underlie inhibition and altered specificity of the multidrug efflux pump AcrB
E. Reading, Z. Ahdash, … A. Politis·bioRxiv·Apr 27, 2020
- Molecular basis for multidrug efflux by an anaerobic RND transporter
Ryan Lawrence, Mohd Athar, … Eamonn Reading·Nature CommunicationsPeer-reviewed·Dec 3, 2025
- Beyond Gatekeeping: Efflux Pumps Remotely Destabilize Cytoplasmic Drug-Target Interactions by Limiting Rebinding.
Subrata Dev, Keiran Stevenson, … Minsu Kim·bioRxiv·Aug 6, 2025
- Quantum dot probes for the quantitative study of drug transport by the MacAB TolC efflux pump in lipid scaffolds
H. Souabni, W. Batista dos Santos, … M. Picard·bioRxiv·Jun 16, 2020